CN115315432A - 亲环蛋白抑制剂及其用途 - Google Patents
亲环蛋白抑制剂及其用途 Download PDFInfo
- Publication number
- CN115315432A CN115315432A CN202180023173.3A CN202180023173A CN115315432A CN 115315432 A CN115315432 A CN 115315432A CN 202180023173 A CN202180023173 A CN 202180023173A CN 115315432 A CN115315432 A CN 115315432A
- Authority
- CN
- China
- Prior art keywords
- compound
- organ
- pharmaceutically acceptable
- donor
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020081296 | 2020-03-26 | ||
| CNPCT/CN2020/081296 | 2020-03-26 | ||
| PCT/CN2021/083015 WO2021190603A1 (en) | 2020-03-26 | 2021-03-25 | Cyclophilin inhibitors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115315432A true CN115315432A (zh) | 2022-11-08 |
Family
ID=77891508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180023173.3A Pending CN115315432A (zh) | 2020-03-26 | 2021-03-25 | 亲环蛋白抑制剂及其用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230203099A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4126903A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023518775A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220158759A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115315432A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021244763A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3172689A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202144378A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021190603A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113329626A (zh) * | 2019-01-20 | 2021-08-31 | 睿诺医疗科技(上海)有限公司 | 环孢菌素类似物及其用途 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116870135A (zh) | 2019-10-12 | 2023-10-13 | 睿诺医疗科技(上海)有限公司 | 肾毒素诱发的肾损伤的治疗和预防 |
| AU2021256222A1 (en) | 2020-04-15 | 2022-10-06 | Farsight Medical Technology (Shanghai) Co., Ltd. | Prevention and treatment of organ injuries |
| CN115028679B (zh) * | 2022-08-11 | 2022-11-15 | 深圳湾实验室 | 一种具有Cyclophilin A降解活性的PROTAC化合物及其制备方法与应用 |
| CN115028681B (zh) * | 2022-08-11 | 2022-11-15 | 中国科学院微生物研究所 | 一种降解亲环素a的嵌合体化合物及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6809077B2 (en) * | 2001-10-12 | 2004-10-26 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogs for the treatment of autoimmune diseases |
| CA2518265A1 (en) * | 2003-03-17 | 2004-09-30 | Albany Molecular Research, Inc. | Novel cyclosporins |
| MX2011001152A (es) * | 2008-07-30 | 2011-06-09 | Isotechnika Pharma Inc | Moleculas de analogo de ciclosporina no-inmunesupresoras. |
| AU2011342284C1 (en) * | 2010-12-15 | 2017-07-13 | Contravir Pharmaceuticals, Inc. | Cyclosporine analogue molecules modified at amino acid 1 and 3 |
| GB201414806D0 (en) * | 2014-08-20 | 2014-10-01 | Ucl Business Plc | Cyclosporin conjugates |
| AU2017267560B2 (en) * | 2016-05-17 | 2022-03-24 | S&T Global Inc. | Novel cyclosporin derivatives and uses thereof |
| GB201711749D0 (en) * | 2017-07-21 | 2017-09-06 | Cypralis Ltd | Cyclosporin analogues and uses thereof |
| CN116870135A (zh) * | 2019-10-12 | 2023-10-13 | 睿诺医疗科技(上海)有限公司 | 肾毒素诱发的肾损伤的治疗和预防 |
-
2021
- 2021-03-25 WO PCT/CN2021/083015 patent/WO2021190603A1/en not_active Ceased
- 2021-03-25 AU AU2021244763A patent/AU2021244763A1/en not_active Abandoned
- 2021-03-25 EP EP21774048.9A patent/EP4126903A4/en not_active Withdrawn
- 2021-03-25 CN CN202180023173.3A patent/CN115315432A/zh active Pending
- 2021-03-25 US US17/906,978 patent/US20230203099A1/en not_active Abandoned
- 2021-03-25 JP JP2022556473A patent/JP2023518775A/ja active Pending
- 2021-03-25 KR KR1020227036425A patent/KR20220158759A/ko not_active Withdrawn
- 2021-03-25 CA CA3172689A patent/CA3172689A1/en active Pending
- 2021-03-25 TW TW110110798A patent/TW202144378A/zh unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113329626A (zh) * | 2019-01-20 | 2021-08-31 | 睿诺医疗科技(上海)有限公司 | 环孢菌素类似物及其用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021244763A1 (en) | 2022-10-06 |
| EP4126903A1 (en) | 2023-02-08 |
| CA3172689A1 (en) | 2021-09-30 |
| KR20220158759A (ko) | 2022-12-01 |
| EP4126903A4 (en) | 2024-05-08 |
| US20230203099A1 (en) | 2023-06-29 |
| TW202144378A (zh) | 2021-12-01 |
| JP2023518775A (ja) | 2023-05-08 |
| WO2021190603A1 (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7776435B2 (ja) | シクロフィリン阻害剤およびその使用 | |
| TW202144378A (zh) | 親環蛋白抑制劑及其用途 | |
| JP7839090B2 (ja) | ネフロトキシン誘発性腎障害の処置及び予防 | |
| JP2017523178A (ja) | 骨髄異形成症候群を治療するためのタンパク質ホスファターゼ2a阻害剤 | |
| KR20160110399A (ko) | 메갈린 길항제 | |
| KR20050119104A (ko) | 치환된 퀴놀린과 치환된 디페닐설폰을 함유하는 조성물과방법 | |
| US12318368B2 (en) | Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor | |
| EA051978B1 (ru) | Ингибиторы циклофилина и их применение | |
| US12435074B2 (en) | Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor | |
| US12398128B2 (en) | Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor | |
| US12297175B2 (en) | Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor | |
| US12384746B2 (en) | Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor | |
| EP1391203A1 (en) | Antitumor agents | |
| KR20060066176A (ko) | 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 신기능 치료제 조성물 | |
| EP2908820A1 (en) | Treatment of pulmonary fibrosis using an inhibitor of cbp/catenin | |
| US20040152772A1 (en) | 1-butyric acid derivatives and the use thereof | |
| EP2601963A1 (en) | N-isovaleroyl-l-glutamyl-l-tryptophan as an agent inhibiting the formation of ulcers in the stomach and the duodenum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |